About Us  |  BVA-100  |  Investor Relations  |  Idant Division  |  Contact Us
 

ABOUT US: management

 
 

8/13/2008 -Daxor Announces a Union Hospital Purchase and a Separate Trial of Blood Volume Analyzer BVA-100.

  

7/31/2008 -(AMEX: DXR) Daxor Corporation Announces Second Quarter 2008 Earnings

  

7/16/2008 -Daxor Announces International Publication of Clinical Study Involving Critically Ill Surgical Patients and Avoidance of Blood Transfusion Errors.

  
 

______________________

 
     
  2008 Proxy Statement  
  2008 Second Quarter Earnings  
  June 2008 10Q  
  2007 Annual Report  
 

 

   
Executive Team >   Menu Options

Home Page

Company

Careers

Contact Us

 

 

 

 

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

 

Joseph Feldschuh, M.D.

President and CEO

Stephen Feldschuh

Chief Operating Officer

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Deanna O'Brien

Vice President, Quality Systems and Regulatory Affairs

John Reyes-Guerra

Vice President, Sales and Marketing

Everis Engstrom

Vice President, Engineering

Gary Fischman, Ph.D.

Vice President, R&D
   
Board of Directors >  

Joseph Feldschuh, M.D.

Chairman of the Board

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Stephen Valentine

Director of the Company

Robert G. Moussa

Director of the Company
   
Medical Advisory Board >  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 


2007 Daxor Corporation. All Rights Reserved.